Skip to main content

Table 1 History and Medication Use in the Prior Year among Zoster Cases and Controls

From: Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study

  Cases Controls
History* (n = 8900) (n = 88032)
   Age mean (SD) 54.7 (24.4) 54.4 (24.2)
   Gender, male % 38.6 44.4
   Asthma % 32.5 31.5
   Asthma exacerbation % 3.3 2.6
   COPD % 10.1 9.6
   COPD exacerbation % 2.2 1.7
   Wheezing % 5.5 4.9
   Other lung disease % 2.8 2.2
   Peak Flow test% 30.1 29.2
   Referral to respiratory physician % 0.5 0.5
   History of varicella % 0.2 0.2
   History of zoster % 0.4 0.1
   Respiratory Hospitalisation % 1.2 0.9
   Cancer % 1.9 1.2
Medications prescribed*   
Inhaled Corticosteroids (ICS) % 47.3 46.6
   Beclometasone % 36.3 36.4
   Budesonide % 6.9 6.8
   Fluticasone % 4.1 3.4
   Other ICS % 0.1 0.1
ICS+ Long acting β-agonist % 11.3 9.9
Long acting β-agonist % 7.7 7.2
Short acting β-agonist % 61 60.1
Other respiratory drugs % 27.7 24.6
Nasal corticosteroids % 10.8 10
Injection corticosteroids % 1.9 1.6
Oral corticosteroids % 19.9 15.2
Antibiotics % 61.5 52.6
Anti-diabetics drugs % 5.6 5
Cardiac drugs % 46.4 42.9